These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 19951134
1. Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations. Hamoda HM, Guild DJ, Gumlak S, Travers BH, Gonzalez-Heydrich J. Expert Rev Neurother; 2009 Dec; 9(12):1747-54. PubMed ID: 19951134 [Abstract] [Full Text] [Related]
3. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. Kaufmann R, Goldberg-Stern H, Shuper A. J Child Neurol; 2009 Jun; 24(6):727-33. PubMed ID: 19491115 [Abstract] [Full Text] [Related]
4. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial. van der Feltz-Cornelis CM, Aldenkamp AP. Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592 [Abstract] [Full Text] [Related]
5. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Torres AR, Whitney J, Gonzalez-Heydrich J. Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271 [Abstract] [Full Text] [Related]
6. Attention deficit hyperactivity disorder in children with epilepsy. Parisi P, Moavero R, Verrotti A, Curatolo P. Brain Dev; 2010 Jan; 32(1):10-6. PubMed ID: 19369016 [Abstract] [Full Text] [Related]
7. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
9. Attention deficit disorder and epilepsy. Schubert R. Pediatr Neurol; 2005 Jan; 32(1):1-10. PubMed ID: 15607597 [Abstract] [Full Text] [Related]
10. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Wernicke JF, Holdridge KC, Jin L, Edison T, Zhang S, Bangs ME, Allen AJ, Ball S, Dunn D. Dev Med Child Neurol; 2007 Jul; 49(7):498-502. PubMed ID: 17593120 [Abstract] [Full Text] [Related]
11. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit]. Bricard C, Boidein F. Encephale; 2001 Jul; 27(5):435-43. PubMed ID: 11760693 [Abstract] [Full Text] [Related]
14. Psychopharmacology of ADHD in adolescents. Greydanus DE, Sloane MA, Rappley MD. Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803 [Abstract] [Full Text] [Related]
15. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies. Santos K, Palmini A, Radziuk AL, Rotert R, Bastos F, Booij L, Fernandes BS. Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530 [Abstract] [Full Text] [Related]
18. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [Abstract] [Full Text] [Related]